Finesand - this is your specialty , I am not as good in locating everything
in the computer ...:)) ,...What I see , that you are great !!!
Just to review few differences :
- they will have less patients in combo ,because of 3 MDR , Pro 140 .. 2.
and when Pro 140 will be approve , they will have even less patients . Less should progress from MDR 2 to 3 .
-They only have combo, we should have combo and mono...
-we have now GvHD study on.
-we have possibly few/many other diseases in some near future ,
I remember Dr P talking how wonderful results they had in animal with MS.
Market Data 
Markets 
AI
